Global and Region-Specific Analyses of Apparent Diffusion Coefficient in Dentatorubral-Pallidoluysian Atrophy

References

1. ↵
   Nagafuchi S, Yanagisawa H, Sato K, et al. Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p. Nat Genet 1994;6:14–18

   CrossRefPubMedWeb of Science
2. ↵
   Knoide R, Ikeuchi T, Onodera O, et al. Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nat Genet 1994;6:9–13

   CrossRefPubMedWeb of Science
3. ↵
   Kanazawa I. Dentatorubral-pallidoluysian atrophy or Naito-Oyanagi disease. Neurogenetics 1998;2:1–17

   CrossRefPubMedWeb of Science
4. ↵
   Naito H, Oyanagi S. Familial myoclonus epilepsy and choreoathetosis: hereditary dentatorubral-pallidoluysian atrophy. Neurology 1982;32:798–807

   Abstract/FREE Full Text
5. ↵
   Miyazaki M, Hashimoto T, Yoneda Y, et al. Proton magnetic resonance spectroscopy on juvenile-onset dentatorubral-pallidoluysian atrophy (DRPLA). Brain Dev 1996;18:142–46

   PubMed
6. ↵
   Basser PJ, Pierpaoli C. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J Magn Res B 1996;111:209–19

   CrossRef
7. ↵
   Cercignani M, Bammer R, Sormani MP, et al. Inter-sequence and inter-imaging unit variabilia of diffusion tensor MR imaging histogram-derived metrics of the brain in healthy volunteers. AJNR Am J Neuroradiol 2003;24:638–43

   Abstract/FREE Full Text
8. ↵
   Mascalchi M, Tessa C, Moretti M, et al. Whole brain apparent diffusion coefficient histogram: a new tool for evaluation of leukoaraiosis. J Magn Reson Imaging 2002;15:144–48

   CrossRefPubMed
9. ↵
   Chun T, Filippi CG, Zimmerman RD, et al. Diffusion changes in the aging human brain. AJNR Am J Neuroradiol 2000;21:1078–83

   Abstract/FREE Full Text
10. ↵
    Nusbaum AO, Tang CY, Buchsbaum MS, et al. Regional and global changes in cerebral diffusion with normal aging. AJNR Am J Neuroradiol 2001;22:136–42

    Abstract/FREE Full Text
11. ↵
    Bozzali M, Franceschi M, Falini A, et al. Quantification of tissue damage in AD using diffusion tensor and magnetization transfer MRI. Neurology 2001;57:1135–37

    Abstract/FREE Full Text
12. ↵
    Nusbaum AO, Tang CY, Wei T, et al. Whole-brain diffusion MR histograms differ between MS subtypes. Neurology 2000;54:1421–27

    Abstract/FREE Full Text
13. ↵
    Yamada M, Wood JD, Shimohata T, et al. Widespread occurrence of intranuclear atrophin-1 accumulation in the central nervous system neurons of patients with dentatorubral-pallidoluysian atrophy. Ann Neurol 2001;49:14–23

    CrossRefPubMedWeb of Science
14. ↵
    Yamada M, Sato T, Tsuji S, et al. Oligodendrocytic polyglutamine pathology in dentatorubral-pallidoluysian atrophy. Ann Neurol 2002;52:670–74

    CrossRefPubMedWeb of Science
15. ↵
    Harris GJ, Codori AM, Lewis RF, et al. Reduced basal ganglia blood flow and volume in pre-symptomatic, gene-tested persons at-risk for Huntington’s disease. Brain 1999;122:1667–78

    Abstract/FREE Full Text
16. ↵
    Munoz E, Mila M, Sanchez A, et al. Dentatorubropallidoluysian atrophy in a Spanish family: a clinical, radiological, pathological, and genetic study. J Neurol Neurosurg Psychiatry 1999;67:811–14

    Abstract/FREE Full Text
17. ↵
    Uyama E, Kondo I, Uchino M, et al. Dentatorubral-pallidoluysian atrophy (DRPLA): clinical, genetic, and neuroradiologic studies in a family. J Neurol Sci 1995;130:146–53

    CrossRefPubMedWeb of Science
18. ↵
    Gardian G, Browne SE, Choi DK, et al. Neuroprotective effects of phenylbutyrate in the N171–82Q transgenic mouse model of Huntington’s disease. J Biol Chem 2005;280:556–63

    Abstract/FREE Full Text
19. ↵
    Kariya S, Hirano M, Uesato S, et al. Cytoprotective effect of novel histone deacetylase inhibitors against polyglutamine toxicity. Neurosci Lett 2005;392:213–15

    PubMed